Edwards' SAPIEN 3 Ultra Transcatheter Heart Valve Receives CE Mark

IRVINE, Calif., Nov. 16, 2018 -- (Healthcare Sales & Marketing Network) -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced it has rece... Devices, Interventional, Cardiology, Regulatory Edwards Lifesciences, SAPIEN 3 Ultra, Transcatheter, Heart Valve
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news